Donna Trawick, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 9268 Travelers Way, Midland, GA 31820 Phone: 706-505-3104 |
Mrs. Jesusa Duncan, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 8008 Garrett Pines Dr, Midland, GA 31820 Phone: 706-566-6756 |
Lakeisha Laverne Walker, Registered Nurse - Hospice Medicare: Not Enrolled in Medicare Practice Location: 9249 Garrett Lake Dr, Midland, GA 31820 Phone: 706-662-4083 |
Andreka Thrash, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 7777 Leaning Pine Ct, Midland, GA 31820 Phone: 706-358-1534 |
Mrs. Kelli Marie Wright, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 9067 Veterans Parkway, Midland, GA 31820 Phone: 706-324-7241 Fax: 706-324-0027 |
Monica Susan Lott, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 11280 Warm Springs Rd, Midland, GA 31820 Phone: 706-580-8089 |
Tiffany White, Registered Nurse - General Practice Medicare: Not Enrolled in Medicare Practice Location: 6540 Mink Dr, Midland, GA 31820 Phone: 706-577-6722 |
Mrs. Cynthia Dianne Avera, R.N. Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 7400 Lynch Rd, Midland, GA 31820 Phone: 706-561-6422 Fax: 706-494-4387 |
News Archive
Transcatheter heart valve technologies are positioned to become the next disruptive influence in cardiovascular medicine and drive a multi-billion dollar market. However, questions remain about the timing of adoption of these new technologies, the numbers and types of patients ultimately benefitting from them, the impact of reimbursement, and where transcatheter technologies pose the greatest threat to the current surgical caseload, especially in light of developments in minimally invasive heart valve surgery technologies.
Researchers funded by the National Institutes of Health have developed a novel mouse model for the vision disorder Leber hereditary optic neuropathy (LHON), and found that they can use gene therapy to improve visual function in the mice. LHON is one of many diseases tied to gene mutations that damage the tiny energy factories that power our cells, called mitochondria.
Interest is high in the development of blood-based tests that can be used to screen individuals for cancer. That isn't new, liquid biopsy industry has attracted attention and investment for the past few years.
GB Sciences, Inc. announced significant preclinical results for their Parkinson's disease ("PD") formulations from the midterm report for their preclinical study being performed by Dr. Lee Ellis of the National Research Council in Halifax, Nova Scotia, CANADA.
› Verified 8 days ago